Beijing Huanya Zhitong

Beijing Huanya Zhitong appears to be a private Chinese medical technology company focused on healthcare innovation rather than drug development. Publicly available descriptions indicate the company works in imaging diagnosis, clinical treatment, laboratory diagnosis, and medical information technology. Evidence from a 2022 Mentice announcement shows that it acted as a purchaser and local counterparty for simulation solutions used in interventional medical education on behalf of the Chinese Medical Education Association. Based on the available information, the company looks more like a medtech, healthcare IT, and medical education solutions business than a biotech or pharmaceutical developer. There is no clear evidence of a therapeutic drug pipeline, named drug assets, or clinical-stage biopharma programs.